EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access

Parkinsonism Exacerbation due to Acute Dopamine Depletion: A Conundrum Revisited

Brett Sterk, Olga Lopez, Eelco F M Wijdicks

Movement Disorders Clinical Practice · 2026-06 · 13 (6) · 1528-1533

DOI: 10.1002/mdc3.70536 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Movement Disorders Clinical Practice, online erschienen am 16.01.2026. Verfasst von Brett Sterk und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Mayo Clinic Rochester, Rochester, MN, USA. Hauptthemen laut MEDLINE: Dopamine, Neuroleptic Malignant Syndrome, Parkinsonian Disorders. Die Arbeit nennt 13 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Fever and worsening rigidity in Parkinson's disease (PD) may resemble neuroleptic malignant syndrome (NMS). We examined PD patients diagnosed with NMS—regardless of whether diagnostic criteria were used—to establish the clinical characteristics and etiology. Cases Among 15 cases, 40% (6/15) required ICU admission, 27% (4/15) required mechanical ventilation, 80% (12/15) recovered, and 20% (3/15) died. 27% (4/15) had a reduction in carbidopa‐levodopa as the primary trigger, 27% (4/15) had sepsis in addition to concurrent reductions in carbidopa‐levodopa, 7% (1/15) had sepsis alone, 33% (5/15) were exposed to new or increased antidopaminergic drugs, and 7% (1/15) had deep brain stimulator (DBS) malfunction. Literature Review Several terms to describe exacerbation of parkinsonism including NMS‐like state and parkinsonism hyperpyrexia syndrome (PHS) have been proposed over the years but may be restrictive in their definitions and confounders exist.

Conclusions

Acute parkinsonism dopamine depletion syndrome (APDDS) might be a more encompassing term to describe to an acute exacerbation of preexisting parkinsonism resulting from recent reduction in dopaminergic or other Parkinson's therapy (eg, DBS failure), or exposure to antidopaminergics. Symptoms include increased rigidity, encephalopathy, hyperthermia, or autonomic instability. Sepsis is a frequent confounder and may be associated with concurrent reduction or discontinuation of carbidopa‐levodopa.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

DopamineNeuroleptic Malignant SyndromeParkinsonian DisordersHumansMaleFemaleAgedCarbidopaLevodopaAged, 80 and overAntiparkinson AgentsDrug Combinations

Stichwörter der Autor:innen

Parkinson's diseaseintensive careneuroleptic malignant syndromeoutcomeparkinsonism hyperpyrexia syndrome

Substanzen

DopamineCarbidopaLevodopacarbidopa, levodopa drug combinationAntiparkinson AgentsDrug Combinations

Autor:innen und Institutionen

  • Department of Neurology, Mayo Clinic Rochester, Rochester, MN, USA.
  • Department of Psychology and Psychiatry, Mayo Clinic Rochester, Rochester, MN, USA.

Zitieren

APA

Sterk, B., Lopez, O., & Wijdicks, E. F. M. (2026). Parkinsonism Exacerbation due to Acute Dopamine Depletion: A Conundrum Revisited. Movement Disorders Clinical Practice, 13(6), 1528-1533. https://doi.org/10.1002/mdc3.70536

Vancouver

Sterk B, Lopez O, Wijdicks EFM. Parkinsonism Exacerbation due to Acute Dopamine Depletion: A Conundrum Revisited. Movement Disorders Clinical Practice. 2026;13(6):1528-1533. doi:10.1002/mdc3.70536

BibTeX
@article{Sterk2026,
  author = {Sterk, Brett and Lopez, Olga and Wijdicks, Eelco F M},
  title = {Parkinsonism Exacerbation due to Acute Dopamine Depletion: A Conundrum Revisited},
  journal = {Movement Disorders Clinical Practice},
  year = {2026},
  volume = {13},
  number = {6},
  pages = {1528--1533},
  doi = {10.1002/mdc3.70536}
}
Kostenlos starten →